The Utility of a Next-Generation Sequencing (NGS) Panel to Identify Germline Mutations Associated with Endometrial Cancer

被引：0
|
作者：
Ring, Kari
Bruegl, Amanda
Allen, Brian
Elkin, Eric
Singh, Nanda
Hartman, Anne-Renee
Daniels, Molly
Broaddus, Russell
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Myriad Genet Inc, Salt Lake City, UT USA
来源：
LABORATORY INVESTIGATION | 2016年 / 96卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1214
引用
收藏
页码：306A / 306A
页数：1
相关论文
共 50 条
  • [1] The Utility of a Next-Generation Sequencing (NGS) Panel to Identify Germline Mutations Associated with Endometrial Cancer
    Ring, Kari
    Bruegl, Amanda
    Allen, Brian
    Elkin, Eric
    Singh, Nanda
    Hartman, Anne-Renee
    Daniels, Molly
    Broaddus, Russell
    MODERN PATHOLOGY, 2016, 29 : 306A - 306A
  • [2] Germline pathogenic mutations in Chinese patients with gastric cancer identified by next-generation sequencing (NGS)
    Zhang, X.
    Zhou, J.
    Zhao, Z.
    Zhang, Y.
    Cai, S.
    ANNALS OF ONCOLOGY, 2019, 30 : 310 - 310
  • [3] Paired Tumor-Normal Next-Generation Sequencing (NGS) to Identify Pathogenic / Likely Pathogenic Germline Mutations in Lung Cancer Patients
    Yi, Y.
    Chen, R.
    Dai, P.
    Zhu, C.
    Huan, J.
    Liu, T.
    Zhao, M.
    Guan, Y.
    Yang, L.
    Xia, X.
    Yi, X.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1795 - S1795
  • [4] Routine tumor next-generation sequencing (NGS) to identify rare germline lung cancer risk mutations in EGFR and ERBB2.
    Chen, Ruthia
    Koeller, Diane R.
    Sholl, Lynette M.
    Rabin, Michael S.
    Yurgelun, Matthew B.
    Chittenden, Anu B.
    Garber, Judy Ellen
    Oxnard, Geoffrey R.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [5] Clinical Utility of a Custom Next-Generation Sequencing (NGS) Panel for Acute Myelogenous Leukemia (AML)
    Johnson, E.
    Goswami, C.
    Comey, D.
    Davis, K.
    Gong, J.
    Uppal, G.
    Bajaj, R.
    Peiper, S.
    Wang, Z.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2014, 16 (06): : 724 - 724
  • [6] Analytic Validation of a Clinical Next-generation Sequencing (NGS) Panel for Somatic Mutations in Uveal Melanoma
    Covington, K. R.
    Meldi-Sholl, L. E.
    Wilkinson, J. K.
    Durante, M. A.
    Decatur, C. L.
    Vargas, D. A.
    Kristen, P. M.
    Oelschlager, K. M.
    Harbour, J.
    Stone, J. F.
    Monzon, F. A.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2018, 20 (06): : 991 - 992
  • [7] Next-generation sequencing to identify driver mutations in cancer of unknown primary
    Loeffler, H.
    Kriegsmann, M.
    Endris, V.
    Pfarr, N.
    Weichert, W.
    Kraemer, A.
    Oncology Research and Treatment, 2015, 38 : 151 - 151
  • [8] Clinical evaluation of panel testing by next-generation sequencing (NGS) for gene mutations in myeloid neoplasms
    Au, Chun Hang
    Wa, Anna
    Ho, Dona N.
    Chan, Tsun Leung
    Ma, Edmond S. K.
    DIAGNOSTIC PATHOLOGY, 2016, 11
  • [9] Clinical evaluation of panel testing by next-generation sequencing (NGS) for gene mutations in myeloid neoplasms
    Chun Hang Au
    Anna Wa
    Dona N. Ho
    Tsun Leung Chan
    Edmond S. K. Ma
    Diagnostic Pathology, 11
  • [10] Germline and somatic variants in ovarian carcinoma: A next-generation sequencing (NGS) analysis
    Andrikopoulou, Angeliki
    Zografos, Eleni
    Apostolidou, Kleoniki
    Kyriazoglou, Anastasios
    Papatheodoridi, Alksistis-Maria
    Kaparelou, Maria
    Koutsoukos, Konstantinos
    Liontos, Michalis
    Dimopoulos, Meletios-Athanasios
    Zagouri, Flora
    FRONTIERS IN ONCOLOGY, 2022, 12
12345